Senti Biosciences Holdings annual r&d spending
2021
2022
2023
2024
2025
Senti Biosciences Holdings R&D Spending Growth & History (SNTI)
Senti Biosciences Holdings's r&d spending was $37.6M for fiscal 2025.
View full Senti Biosciences Holdings company overviewSenti Biosciences Holdings annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $37.6M | $3.2M | +9.40% |
| 2024 | 2024-12-31 | $34.4M | $2.2M | +6.86% |
| 2023 | 2023-12-31 | $32.1M | $4.0M | +14.23% |
| 2022 | 2022-12-31 | $28.1M | $6.2M | +28.18% |
| 2021 | 2021-12-31 | $22.0M | — | — |
Senti Biosciences Holdings quarterly r&d spending
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.8M | −$2.3M | −22.55% |
| Q1 2026 | 2026-03-31 | $5.3M | −$4.0M | −43.10% |
| Q4 2025 | 2025-12-31 | $7.8M | −$11,000 | −0.14% |
| Q3 2025 | 2025-09-30 | $10.5M | $1.9M | +21.50% |
| Q2 2025 | 2025-06-30 | $10.0M | $878,000 | +9.59% |
| Q1 2025 | 2025-03-31 | $9.3M | $502,000 | +5.72% |
| Q4 2024 | 2024-12-31 | $7.8M | −$1.4M | −14.82% |
| Q3 2024 | 2024-09-30 | $8.7M | −$437,000 | −4.81% |
| Q2 2024 | 2024-06-30 | $9.2M | $2.3M | +33.09% |
| Q1 2024 | 2024-03-31 | $8.8M | $1.7M | +24.37% |
| Q4 2023 | 2023-12-31 | $9.1M | $4.3M | +91.02% |
| Q3 2023 | 2023-09-30 | $9.1M | $2.6M | +39.47% |
| Q2 2023 | 2023-06-30 | $6.9M | −$2.4M | −25.64% |
| Q1 2023 | 2023-03-31 | $7.1M | −$544,000 | −7.16% |
| Q4 2022 | 2022-12-31 | $4.8M | — | — |
| Q3 2022 | 2022-09-30 | $6.5M | $1.1M | +20.50% |
| Q2 2022 | 2022-06-30 | $9.2M | $4.0M | +76.64% |
| Q1 2022 | 2022-03-31 | $7.6M | — | — |
| Q3 2021 | 2021-09-30 | $5.4M | — | — |
| Q2 2021 | 2021-06-30 | $5.2M | — | — |
Senti Biosciences Holdings r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Senti Biosciences Holdings's r&d spending increased from $22.0M to $37.6M, a change of $15.6M. The latest reported quarter, Q2 2026, shows $7.8M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings source filings ↗